Profund Advisors LLC Sells 1,193 Shares of Laboratory Corp. of America Holdings (LH)

Profund Advisors LLC trimmed its stake in shares of Laboratory Corp. of America Holdings (NYSE:LH) by 25.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,499 shares of the medical research company’s stock after selling 1,193 shares during the quarter. Profund Advisors LLC’s holdings in Laboratory Corp. of America were worth $558,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the business. Valeo Financial Advisors LLC acquired a new stake in shares of Laboratory Corp. of America in the 3rd quarter valued at approximately $444,000. Cubist Systematic Strategies LLC lifted its holdings in shares of Laboratory Corp. of America by 233.1% in the 3rd quarter. Cubist Systematic Strategies LLC now owns 10,599 shares of the medical research company’s stock valued at $1,600,000 after buying an additional 7,417 shares during the period. MUFG Americas Holdings Corp lifted its holdings in shares of Laboratory Corp. of America by 5.4% in the 3rd quarter. MUFG Americas Holdings Corp now owns 18,857 shares of the medical research company’s stock valued at $2,847,000 after buying an additional 966 shares during the period. Caisse DE Depot ET Placement DU Quebec lifted its holdings in shares of Laboratory Corp. of America by 1.9% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 41,990 shares of the medical research company’s stock valued at $6,366,000 after buying an additional 800 shares during the period. Finally, Sivik Global Healthcare LLC acquired a new stake in shares of Laboratory Corp. of America in the 3rd quarter valued at approximately $2,098,000. 92.32% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

Laboratory Corp. of America Holdings (NYSE LH) opened at $170.58 on Tuesday. Laboratory Corp. of America Holdings has a one year low of $134.19 and a one year high of $181.71. The firm has a market capitalization of $17,713.28, a P/E ratio of 13.97, a P/E/G ratio of 1.46 and a beta of 0.90. The company has a quick ratio of 1.20, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.

Laboratory Corp. of America (NYSE:LH) last released its quarterly earnings data on Tuesday, February 6th. The medical research company reported $2.45 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.07. The firm had revenue of $2.70 billion during the quarter, compared to the consensus estimate of $2.70 billion. Laboratory Corp. of America had a return on equity of 16.30% and a net margin of 12.15%. Laboratory Corp. of America’s quarterly revenue was up 13.2% on a year-over-year basis. During the same period last year, the business posted $2.15 EPS. equities analysts predict that Laboratory Corp. of America Holdings will post 11.54 earnings per share for the current fiscal year.

Several analysts have recently commented on LH shares. Zacks Investment Research cut Laboratory Corp. of America from a “hold” rating to a “sell” rating in a report on Wednesday, January 3rd. Mizuho set a $178.00 price target on Laboratory Corp. of America and gave the company a “hold” rating in a report on Wednesday, January 24th. Barclays raised their price target on Laboratory Corp. of America from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Monday, February 26th. They noted that the move was a valuation call. Jefferies Group set a $167.00 price target on Laboratory Corp. of America and gave the company a “hold” rating in a report on Friday, November 24th. Finally, ValuEngine raised Laboratory Corp. of America from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Six research analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $188.33.

In other Laboratory Corp. of America news, CFO Glenn A. Eisenberg sold 8,400 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $167.36, for a total transaction of $1,405,824.00. Following the completion of the transaction, the chief financial officer now owns 15,931 shares of the company’s stock, valued at $2,666,212.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Adam H. Schechter sold 1,263 shares of the firm’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $169.29, for a total value of $213,813.27. Following the transaction, the director now directly owns 7,297 shares of the company’s stock, valued at approximately $1,235,309.13. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Profund Advisors LLC Sells 1,193 Shares of Laboratory Corp. of America Holdings (LH)” was published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.thestockobserver.com/2018/03/20/profund-advisors-llc-sells-1193-shares-of-laboratory-corp-of-america-holdings-lh.html.

About Laboratory Corp. of America

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corp. of America Holdings (NYSE:LH).

Institutional Ownership by Quarter for Laboratory Corp. of America (NYSE:LH)

Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply